Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
JAMA Cardiology
|
January 6, 2021
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial
Massar Omar, Jesper Jensen, Mulham Ali, et al.
JACC. Advances
|
October 24, 2025
Albuminuria in Type 2 Diabetes and Risk of Cardiorenal Outcomes
Saaima Parveen, Morten Malmborg, Anojhaan Arulmurugananthavadivel, et al.
Journal of Clinical Lipidology
|
January 22, 2025
Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure - Empire HF and SIMPLE
Frida Emanuelsson, Jesper Jensen, Massar Omar, et al.
Journal of the American College of Cardiology
|
December 4, 2020
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Peter H Frederiksen, et al.
Optics Express
|
June 2, 2009
Ultra-large bandwidth hollow-core guiding in all-silica Bragg fibers with nano-supports
Guillaume Vienne, Yong Xu, Christian Jakobsen, et al.
Trials
|
June 23, 2019
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Jesper Jensen, Massar Omar, Caroline Kistorp, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Peter H Frederiksen, et al.
ESC Heart Failure
|
February 19, 2026
Effects of Empagliflozin on Right Ventricular Free-Wall Strain in Patients with Heart Failure and Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Mulham Ali, et al.
The Lancet. Healthy Longevity
|
September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study
Mariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
Journal of the American Heart Association
|
April 9, 2026
Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022
Sofie-Louise Feentved Ødum, Clara Friis, Caroline Hartwell Garred, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
JAMA Cardiology
|
January 6, 2021
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial
Massar Omar, Jesper Jensen, Mulham Ali, et al.
JACC. Advances
|
October 24, 2025
Albuminuria in Type 2 Diabetes and Risk of Cardiorenal Outcomes
Saaima Parveen, Morten Malmborg, Anojhaan Arulmurugananthavadivel, et al.
Journal of Clinical Lipidology
|
January 22, 2025
Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure - Empire HF and SIMPLE
Frida Emanuelsson, Jesper Jensen, Massar Omar, et al.
Journal of the American College of Cardiology
|
December 4, 2020
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Peter H Frederiksen, et al.
Optics Express
|
June 2, 2009
Ultra-large bandwidth hollow-core guiding in all-silica Bragg fibers with nano-supports
Guillaume Vienne, Yong Xu, Christian Jakobsen, et al.
Trials
|
June 23, 2019
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Jesper Jensen, Massar Omar, Caroline Kistorp, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Peter H Frederiksen, et al.
ESC Heart Failure
|
February 19, 2026
Effects of Empagliflozin on Right Ventricular Free-Wall Strain in Patients with Heart Failure and Reduced Ejection Fraction
Massar Omar, Jesper Jensen, Mulham Ali, et al.
The Lancet. Healthy Longevity
|
September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study
Mariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
Journal of the American Heart Association
|
April 9, 2026
Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022
Sofie-Louise Feentved Ødum, Clara Friis, Caroline Hartwell Garred, et al.
Page
of 8